Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Biotech’s Hard Bargain

Investors love drug companies in part because they often have tremendous pricing power. Drugs designed to fight rare diseases routinely cost two or three hundred thousand dollars; cancer drugs often cost a hundred grand. But the signs of a backlash are clear.

Published
1 hour ago
From
The New Yorker
How Sensationalist Media Coverage Hurts The Fight Against HIV

Significant steps have been taken in the fight against HIV/AIDS over the past several years, but media coverage of the issue all too often fixates on stories that sensationalize the spread of the disease and even encourage the criminalization of people with HIV.

Published
4 hours ago
From
Media Matters for America (blog)
Why Russia is Heading Toward an HIV Crisis and Privacy Disaster

Russian lawmakers are said to be moving on a bill that would mandate every citizen living with HIV/AIDS must submit to fingerprint data collection, a worrying turn of events in a country that is already seeing the damages of a disastrous HIV policy.

Published
23 April 2014
From
Care2.com
Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Gilead Sciences Inc. (GILD) overwhelmed sales estimates for its new blockbuster hepatitis C pill in what analysts called the biggest drug start ever, raising questions about insurers’ ability to slow the use of the costly therapy.

Published
23 April 2014
From
Bloomberg
While HIV aid drops, overall global health spending shows “enduring support”

While development assistance to middle and low-income countries for global health reached an all-time high last year, assistance for “the main infectious diseases, HIV/AIDS, tuberculosis, and malaria, contracted on the whole,” according to the Financing Global Health 2013: Transition in an Age of Austerity report published by the Institute of Health Metrics and Evaluation.

Published
22 April 2014
From
Science Speaks
Early Data Suggests Many With HIV Accessed Obamacare

A significant proportion of those accessing marketplace insurance plans through Obamacare are people with HIV, according to a study from a major pharmacy benefits manager.

Published
22 April 2014
From
AIDSMeds
Motorbikes Speed Up HIV Test Results in Malawi

Improvements to Malawi’s network for transporting laboratory samples will help people living with HIV get vital test results quicker. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) plans to work with motorcycle couriers Riders for Health to expand the laboratory samples transportation network in Malawi.

Published
22 April 2014
From
Bill & Melinda Gates Foundation (blog)
Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s refiling of two New Drug Applications (NDA) for cobicistat, a pharmacoenhancing or “boosting” agent that increases blood levels of the protease inhibitors atazanavir and darunavir to enable once-daily dosing of these medicines in HIV therapy, and elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

Published
22 April 2014
From
Gilead press release
People living with HIV in the UK still have impaired health-related quality of life

People living with HIV in the UK have poorer health-related quality of life (HRQoL) compared to individuals in the general population, according to research presented at the

Published
22 April 2014
By
Michael Carter
NHS England agrees funding for life-saving hepatitis C drug

NHS England has approved an £18.7 million investment in a new drug for the treatment of hepatitis C. Around 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Sofosbuvir.

Published
17 April 2014
From
NHS England (press release)
← First12345...420Next →

Filter by country